| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Likeable Bosses |
|
Digg It - Likeable Bosses
“Survey suggests bosses not as likable as they think they are”
Shanghai Daily, 24 April 2007 A re According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product cent survey by 51job.com in China found that almost 60% of employees identified their supervisors a ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s "order-issuing lovers" and another 18% referred to their bosses as "critics". In contrast, more t lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. an 82% of leaders considered themselves good leaders and friendly to their subordinates. The artic here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe le suggests these contrasting perspectives are most pronounced in China with its traditional author d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro tarian culture and lack of flexibility in leadership styles. While that may be true, perhaps the st ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc atement "It's not easy for people to find problems with themselves" is universal. Do bosses need t easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi be liked? People respond to authority, particularly in a place like China; that is, until the next nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically opportunity presents itself. Western conventional wisdom suggests that it is important to build tr and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ st, credibility and respect; there is no need to be liked. When those characteristics are combined ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi with strong leadership, people will follow...as long as they are realizing benefits for themselves. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a The question then becomes if we can combine trust, credibility, respect, leadership and likeabilit dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod , can we drive even greater results? Tim Sanders in "The Likeability Factor" defines likeability a cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s your capacity to produce positive attitudes in other people about you. This usually create positi tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen e emotions in others. He argues that people are constantly making choices - whether to listen to yo t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel u, whether to believe you and whether to value what you offer. Likeability affects all of these. H ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust breaks down likeability into four elements.
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Who Is Your Business Plan For? CASH - Choosing Exhibition Gifts The Importance Of Happy Employees
|